| D013449 |
Sulfonamides |
A group of compounds that contain the structure SO2NH2. |
Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide |
|
| D014125 |
Toxoplasmosis, Congenital |
Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735) |
Congenital Toxoplasma gondii Infection,Toxoplasmosis, Fetal,Toxoplasmosis, Prenatal,Congenital Infection, Toxoplasma gondii,Congenital Toxoplasma Infections,Congenital Toxoplasmosis,Toxoplasma Infections, Congenital,Congenital Toxoplasma Infection,Congenital Toxoplasmoses,Fetal Toxoplasmoses,Fetal Toxoplasmosis,Infection, Congenital Toxoplasma,Infections, Congenital Toxoplasma,Prenatal Toxoplasmoses,Prenatal Toxoplasmosis,Toxoplasma Infection, Congenital,Toxoplasmoses, Congenital,Toxoplasmoses, Fetal,Toxoplasmoses, Prenatal |
|
| D014126 |
Toxoplasmosis, Ocular |
Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness. |
Ocular Toxoplasmosis,Ocular Toxoplasmoses,Toxoplasmoses, Ocular |
|